A Trial To Evaluate The Efficacy And Safety Of Fesoterodine In Patients With Symptoms Of Overactive Bladder Including Nocturnal Urinary Urgency

Status:
Completed

Trial end date:
2011-09-01

Target enrollment:

Participant gender:

This study is designed to assess the efficacy of a flexible dose regimen of fesoterodine on micturition related nocturnal urgency episodes.

Phase 4

Pfizer

Fesoterodine